The proposed trial for a hepatitis B vaccine involving newborns in Guinea-Bissau is currently on hold, as local officials have yet to grant their approval. In a recent press briefing, health minister Quinhin Nantote stated that the government has not authorized the trial, emphasizing the necessity for compliance with national laws and ethical considerations in any research involving human subjects.

Nantote remarked, “Any scientific research initiative involving human beings, particularly children, must strictly adhere to applicable national legislation, international ethical principles, and competent evaluation processes.” This statement underscores the seriousness with which the government is approaching the proposed study.

In response to circulating rumors suggesting that the trial would commence, Nantote firmly denied these claims, stating, “This is not even remotely true.” His comments highlight the ongoing scrutiny surrounding the trial’s ethical implications.

Compounding the situation, the government has initiated an investigation into the activities of researchers Aaby and Stabell Benn. A Facebook post from the judicial police announced that they conducted a search at the Bandim Health Project in the capital city, Bissau. This operation led to the confiscation of a quantity of hepatitis B vaccines intended for children, which the authorities state is part of an effort to clarify the circumstances surrounding the batch.

The police remarked that this seizure is merely an investigatory step and should not be interpreted as an indication of any irregularities concerning the vaccines’ quality, safety, or efficacy.